ANTXR2 and soft tissue sarcoma: In Kaplan-Meier survival analyses, CMG2 mRNA expression was significantly associated with patients’ disease-specific survival, with a median survival time of 25 months for soft tissue sarcoma patients with a low CMG2 mRNA expression (n = 30), in comparison to 90 months for patients with an elevated CMG2 mRNA expression (n = 91; p = 0.013; log-rank test; see Figure 3a).